← Leaderboards
Chung-Jen James Chou
Medical University Of South Carolina
$1,864,135
Attributed
$2,186,771
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $349.9K · FY2013–21$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,186,771 · 3
By mechanism
R01$1,541,499 · 1
R41$645,272 · 2
Top collaborators
- Zhi Zhong2 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- John J Lemasters$27,282,033
- Jennifer S Isaacs$3,275,952
- Kenneth D Chavin$1,704,195
- Keely Morris$168,513
- Shaun Olsen$5,925,865
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadToxic EffectDrug KineticsPropertyIn VivoPlayInnovationHistone DeacetylaseClinicCellsCell DeathPhysiologicalTumorAffectAttenuatedIsoenzymesApoptosisCytotoxic ChemotherapyAcetylationCell LineCytotoxicityAcute LeukemiaBiological MarkersBiological
Grant awards (7)
Treatment of liver fibrosis with oral hepatic stable and non-genotoxic HDAC inhibitors$349,908
R41 · FY2021 · DK
Next generation HDAC inhibitors with superior potency, selectivity, and pharmacokinetic profiles for the treatment of liver ischemia-reperfusion injury$295,364
R41 · FY2019 · DK
Novel lysine deacetylase 6 Hsp domain inhibitors against AML$310,213
R01 · FY2017 · CA · contact PI
Novel lysine deacetylase 6 Hsp domain inhibitors against AML$310,213
R01 · FY2016 · CA · contact PI
Novel lysine deacetylase 6 Hsp domain inhibitors against AML$310,213
R01 · FY2015 · CA · contact PI
Novel lysine deacetylase 6 Hsp domain inhibitors against AML$300,907
R01 · FY2014 · CA · contact PI
Novel lysine deacetylase 6 Hsp domain inhibitors against AML$309,953
R01 · FY2013 · CA · contact PI